Cargando…
Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells
Temozolomide (TMZ) is an alkylating chemotherapeutic agent widely used in anti-glioma treatment. However, acquired TMZ resistance represents a major clinical challenge that leads to tumor relapse or progress. This study investigated the genomic profiles including long non-coding RNA (lncRNA) and mRN...
Autores principales: | Zeng, Huijun, Xu, Ningbo, Liu, Yanting, Liu, Boyang, Yang, Zhao, Fu, Zhao, Lian, Changlin, Guo, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505000/ https://www.ncbi.nlm.nih.gov/pubmed/28714520 http://dx.doi.org/10.3892/ijo.2017.4033 |
Ejemplares similares
-
Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma
por: Xu, Ningbo, et al.
Publicado: (2018) -
Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling
por: Zeng, Huijun, et al.
Publicado: (2017) -
LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma
por: Liu, Boyang, et al.
Publicado: (2020) -
Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines
por: Liu, Yanting, et al.
Publicado: (2016) -
Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis
por: Hiddingh, Lotte, et al.
Publicado: (2014)